InterCure Ltd. (NASDAQ:INCR – Get Free Report)’s stock price was down 3.4% on Monday . The company traded as low as $1.43 and last traded at $1.44. Approximately 37,166 shares changed hands during trading, a decline of 6% from the average daily volume of 39,383 shares. The stock had previously closed at $1.49.
InterCure Price Performance
The stock has a 50-day moving average of $1.63 and a two-hundred day moving average of $1.63. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.78 and a quick ratio of 1.15.
Hedge Funds Weigh In On InterCure
Several large investors have recently bought and sold shares of the stock. Virtu Financial LLC bought a new position in InterCure in the 3rd quarter valued at $43,000. Jane Street Group LLC acquired a new stake in InterCure during the 3rd quarter worth $49,000. Finally, Moore Capital Management LP acquired a new position in shares of InterCure in the 4th quarter valued at approximately $156,000. 8.34% of the stock is currently owned by institutional investors and hedge funds.
About InterCure
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Recommended Stories
- Five stocks we like better than InterCure
- How Investors Can Find the Best Cheap Dividend Stocks
- Energy Transfer: Powering Data With Dividends and Diversification
- How to Calculate Return on Investment (ROI)
- Qualcomm Stock Is Coiling for a Breakout
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.
